Share this story:

AREV Nutrition Sciences Inc. Annual General and Special Meeting

Vancouver, British Columbia / TheNewswire / July 10, 2018 - AREV Nutrition Sciences Inc. ("AREV" or the "Company") (CSE - AREV), is pleased to announce that it held its annual general and special meeting on Friday, June 29, 2018 at Suite 1780, 400 Burrard Street, Vancouver, B.C. at the hour of 10:00 a.m. (Vancouver time) (the "Meeting"). At the Meeting, shareholders elected Mike Withrow, Stephane Maher, Nils Rehmann, Guy Dancosse and Scott McDermid to the Company's board of directors (the "Board"). Shareholders also approved all other matters tabled at the meeting, as set out in the Company's management information circular dated June 1, 2018. This included a name change to AREV Brands International Ltd, which name change will take effect upon CSE approval.

Further, the Company announces that it will not be proceeding with the proposed transaction with We Grow BC Ltd. which has been terminated. Both parties contributed significantly towards the proposed transaction and the Board of Company would like to thank everyone for their efforts. The Board is pleased to announce that the Company's shareholders shall benefit from less dilution and more focus on the Company's existing assets and future prospects consistent with the corporate mandates of the Company.

For further information, contact Stephane Maher, CEO at

On behalf of the Board,

Stephane Maher
Chief Executive Officer & Director

About AREV Nutrition Sciences Inc.
AREV Nutrition Sciences Inc. ("AREV") produces and delivers functional ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of coconut oil, whey protein and nutrients through emulsification. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV is also working with Pharmacy and Dispensary operators with an innovative emulsified base formula to disperse Cannabis oil extracts from specific selected genetic Cannabis strains that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.



Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on